Does Letrozole Make You Tired? Here’s Why

Letrozole causes clinically meaningful fatigue in a large share of women who take it. In a study of over 1,100 breast cancer survivors on aromatase inhibitors, roughly 56% reported moderate to severe fatigue, while only about 14% reported no fatigue at all.¹ The tiredness is not “in your head,” and it is not just about cancer itself. Letrozole’s core mechanism, slashing estrogen to near-zero levels, sets off a chain of biological effects that converge on fatigue from several directions at once.

How Common the Fatigue Really Is

If you feel exhausted on letrozole and wonder whether other people experience the same thing, the numbers are clear. In the study above, participants rated their worst fatigue on a 0–10 scale. About 31% scored in the severe range (7–10), another 25% fell in the moderate range (4–6), and roughly 30% reported mild fatigue. Barely one in seven said they had none at all.¹ That makes fatigue one of the most prevalent side effects of aromatase inhibitor therapy, not a fringe complaint.

It is worth noting that fatigue shows up as a side effect with tamoxifen and other endocrine therapies too, but the profile differs. Systematic reviews of self-management strategies for endocrine therapy side effects list fatigue as a common complaint across both tamoxifen and aromatase inhibitor users, with joint pain being especially prominent among women on aromatase inhibitors like letrozole.² When women switch from a nonsteroidal aromatase inhibitor (letrozole or anastrozole) to the steroidal one (exemestane), fatigue has been reported in about 10% of switchers, alongside much higher rates of joint pain and hot flashes.³ So fatigue tracks with aromatase inhibitor use generally, not just one specific drug in the class.

Estrogen Deprivation and the Inflammatory Cascade

The root cause of letrozole-related fatigue starts with what the drug is designed to do. Letrozole blocks the aromatase enzyme, which is the body’s primary tool for making estrogen after menopause. The result is an extremely low estrogen state, far lower than what natural menopause produces. Estrogen does a lot more than regulate the reproductive system. Among its lesser-known jobs, it helps keep inflammatory signaling in check. When estrogen drops, the body’s production of inflammatory cytokines can ramp up.⁴

That uptick in inflammation connects directly to tiredness. A study of 203 women on aromatase inhibitors found that the severity of joint pain, fatigue, and insomnia were all significantly correlated with one another. More importantly, the cluster of all three symptoms together was linked to elevated levels of C-reactive protein (a well-known marker of systemic inflammation) as well as other immune-signaling molecules like eotaxin and monocyte chemoattractant protein-1.⁵ In other words, the fatigue is not just a vague feeling of being tired. It appears to share an underlying inflammatory biology with the joint pain and insomnia that so many women on letrozole also report. These three symptoms tend to travel together, and treating them as isolated complaints misses the bigger picture.

Night Sweats, Broken Sleep, and Next-Day Exhaustion

One of the most direct routes from letrozole to fatigue runs through the bedroom. Hot flashes and night sweats are among the most common side effects of any estrogen-lowering therapy. When those vasomotor symptoms happen at night, they fragment sleep in a way that is hard to compensate for. A qualitative study of women dealing with menopause-related vasomotor symptoms found that over 93% said their symptoms affected sleep, mostly through sweating or overheating that woke them up and made it difficult to fall back asleep.⁶

The downstream effects were wide-ranging. Women reported that the sleep disruption from vasomotor symptoms impaired their next-day work productivity, mood, ability to concentrate, relationships, and physical health.⁶ For women on letrozole, whose estrogen is pushed to levels even lower than natural menopause, this cycle of hot flush → broken sleep → daytime exhaustion can be relentless. It is one of those feedback loops that makes the fatigue feel inescapable: you are tired because you did not sleep, and you did not sleep because of a side effect of the drug that you need to keep taking.

Joint Pain as a Hidden Driver of Fatigue

Letrozole-related joint pain (arthralgia) is discussed so often as its own problem that people sometimes forget how profoundly it contributes to fatigue. Living with chronic pain is draining in itself. But the connection is more than psychological. The same inflammatory study mentioned earlier showed that arthralgia, fatigue, and insomnia share overlapping inflammatory biomarkers, suggesting a common biological mechanism rather than just pain making you tired in a general sense.⁵

A randomized trial of electroacupuncture in breast cancer patients with aromatase inhibitor-related joint pain found that baseline pain interference was strongly correlated with fatigue and moderately correlated with sleep disturbance and depression.⁷ This matters for practical reasons: addressing joint pain with your oncologist may do more for your energy than you would expect, precisely because pain, fatigue, and poor sleep are entangled biologically, not just experientially. If your fatigue worsened around the same time your joints started hurting, that is not a coincidence.

When Thyroid Problems Add to the Problem

Breast cancer and its treatments can disrupt thyroid function, and hypothyroidism is one of the classic medical causes of fatigue. A study tracking thyroid function in breast cancer patients found that women with breast cancer were significantly more likely to develop subclinical or overt hypothyroidism over the first year compared to controls without cancer (about 10% versus 5%).⁸ The same study found that breast cancer patients reported significantly worse fatigue than age-matched controls, with the strongest effects in women with a BMI over 30. In that subgroup, the interaction between cancer status and fatigue disruption over time was especially pronounced.

This is relevant for anyone on letrozole who feels that their fatigue is worse than other people’s accounts or worse than it “should be.” It is worth asking your doctor to check thyroid levels with a simple blood test. If subclinical hypothyroidism is quietly contributing to your exhaustion, it is treatable, and treating it could meaningfully reduce your overall fatigue burden even while you stay on letrozole.

Body Composition Changes and Muscle Loss

Another contributor to fatigue that tends to creep in gradually is the shift in body composition that aromatase inhibitors promote. A study following early breast cancer patients on adjuvant aromatase inhibitor therapy found that fat mass increased by roughly 8–10% while lean mass decreased by about 3% over the course of treatment. The proportion of patients meeting criteria for sarcopenia (significant loss of muscle mass), obesity, and sarcopenic obesity all increased during therapy.⁹

Losing muscle while gaining fat makes everyday activities feel harder. Climbing stairs, carrying groceries, even standing for long periods requires more effort when you have less muscle to work with and more weight to move. This kind of fatigue is different from the inflammatory or sleep-related types, more like a gradual erosion of physical capacity that you might not attribute to the drug unless someone points it out. It also compounds the other fatigue mechanisms: if you are already sleeping poorly and dealing with low-grade inflammation, losing muscle mass on top of that can make the exhaustion feel unmanageable.

Potential Heart-Related Pathways

There is also emerging preclinical evidence suggesting that letrozole may affect the heart’s energy metabolism. Animal research showed that female rats exposed to letrozole for four weeks developed metabolic changes in the heart, including a shift away from the heart’s preferred fuel source (fatty acid oxidation) toward glycolysis, a less efficient energy pathway. This was accompanied by structural changes in the left ventricle.¹⁰ The researchers suggested that this kind of cardiac metabolic remodeling could predispose the heart to reduced efficiency over time.

This is animal data, so drawing direct conclusions for patients is premature. But it raises an interesting possibility that some of the fatigue women experience on letrozole could have a cardiovascular component, particularly during physical exertion. If the heart is running on a less efficient fuel mix, it would make sense for exercise tolerance to decline. This remains an area where more human research is needed, but it is one of those findings that makes researchers pay closer attention to cardiovascular monitoring in women on long-term aromatase inhibitor therapy.

Why Fatigue Makes People Stop Treatment

Fatigue is not just an inconvenience. It is one of the reasons women stop taking their aromatase inhibitor before the prescribed course is finished, and stopping early can affect cancer outcomes. In a trial comparing letrozole to exemestane, about 32% of patients discontinued treatment before 24 months because of toxicity. Of those randomly assigned to exemestane, 36% stopped early, compared with about 28% of those on letrozole.¹¹ Fatigue, alongside joint pain and other quality-of-life burdens, drives these decisions.

This creates a real tension. The drug is protective, but if the side effects are severe enough that you cannot function, staying on it becomes a daily struggle. If fatigue is pushing you toward stopping letrozole, that conversation with your oncologist is one of the most important ones you can have. There are options: switching to a different aromatase inhibitor, dose adjustments, addressing the contributing factors outlined above, or in some cases transitioning to tamoxifen. Quietly stopping the drug on your own, which happens more often than clinicians realize, bypasses the chance to find a workable solution.

What Actually Helps With the Exhaustion

The most counterintuitive piece of advice for letrozole-related fatigue is to exercise. When you are bone-tired, the last thing that feels reasonable is going for a walk or attending a yoga class. But the evidence is surprisingly strong. An overview of systematic reviews found moderate-certainty evidence that exercise improves cancer-related fatigue in breast cancer patients, with a meaningful effect size. Yoga and aerobic exercise both showed significant benefit. Exercising for more than six months, three times per week, for sessions lasting 30 to 60 minutes produced the most notable improvements. Supervised exercise programs had a larger effect than unsupervised ones.¹²

The practical takeaway is that starting small and building consistency matters more than intensity. Even gentle walking or restorative yoga counts as a starting point. Over months, regular movement appears to counteract several of the fatigue mechanisms at once: it reduces inflammation, preserves lean muscle mass, improves sleep quality, and lifts mood. If you can access a supervised exercise program through a cancer center or rehabilitation service, the data suggests it will work better than doing it alone, probably because accountability and expert guidance help you stick with it during the weeks when you feel least motivated.

Beyond exercise, the other practical steps align with the contributing causes discussed above:

Manage joint pain proactively: Because pain, fatigue, and poor sleep share inflammatory biology, getting joint pain under control with appropriate medication or physical therapy can improve energy levels indirectly.
Address sleep disruption: If night sweats are wrecking your sleep, talk to your doctor about managing vasomotor symptoms. Cooling bedding, room temperature adjustments, and in some cases prescribed medications can help.
Check thyroid levels: A simple blood test can rule out or identify hypothyroidism as an additive cause of your fatigue.
Preserve muscle mass: Resistance training, even light, helps offset the lean-mass loss that aromatase inhibitors promote.

The Depression and Fatigue Overlap

Depression and fatigue share so many symptoms that they can be hard to disentangle. Feeling exhausted, losing motivation, struggling to concentrate, and withdrawing from activities are features of both. In women on aromatase inhibitors, the overlap is more than superficial. The trial examining electroacupuncture for aromatase inhibitor-related arthralgia found that pain interference was strongly correlated with both fatigue and depression at baseline.⁷ Pain, poor sleep, low mood, and fatigue form a cluster where each element reinforces the others.

This matters because if depression is part of the picture, treating it can break the cycle. Many women on letrozole assume their exhaustion is purely physical, a drug side effect they have to endure. And it partly is. But if a screening conversation with a mental health professional reveals significant depressive symptoms, addressing those with therapy, medication, or both could lift the fatigue in ways that no amount of sleep hygiene or exercise alone would accomplish. The point is not that fatigue on letrozole is “really” depression. It is that both conditions can coexist and amplify each other, and treating one without considering the other leaves improvement on the table.

How Long the Fatigue Lasts

For most women, letrozole is prescribed for five years, sometimes extended to seven or ten in high-risk cases. That is a long time to be tired. Research on fatigue trajectories during aromatase inhibitor use is still limited compared to what we know about joint pain, but clinical experience and patient reports suggest the fatigue can persist for the entire duration of treatment. Some women find it worst in the first few months as their body adjusts to a near-zero estrogen state, with gradual improvement after that. Others describe it as relatively stable throughout, or even worsening over time as muscle loss accumulates and sleep debt builds.

After stopping letrozole, most women see improvements as estrogen levels partially recover (in postmenopausal women, levels rise but do not return to premenopausal values). How quickly that improvement comes varies. Some women feel a noticeable energy boost within weeks of stopping. Others, especially those who developed thyroid problems, sarcopenia, or significant deconditioning during treatment, find that recovery takes longer and may require active rehabilitation. If you are nearing the end of your prescribed course and planning for what comes next, raising the topic of post-treatment recovery with your care team can help set realistic expectations and line up support.